Cencora Inc

COR's Fundamental analysis

Select the Comparisons :

None ▼

Select the Ratio:

None▼

None ▼

None▼

COR Growth rates comparisons

Looking into Cencora Inc growth rates, revenue grew by 8.65 % in the third quarter of 2025 from the same quarter a year ago. Ranking at No. 2137

Pharmacy Services & Retail Drugstore industry recorded growth of revenues by 10.41 %

Cencora Inc 's net income grew by 41.46 % in third quarter of 2025 year on year, above company average,

• More on COR's Growth

COR's Valuation comparisons

Cencora Inc
current PE on trailing twelve month basis is below Pharmacy Services & Retail Drugstore industry average.

Cencora Inc realized cash reduction of $ -6.15 per share in trailing twelve-month period.

Company

35.09

PE TTM

Industry

61.53

PE TTM

Company's Price to Sales ratio is at 0.21.
Pharmacy Services & Retail Drugstore industry's Price to Sales ratio is at 0.24.

• More on COR's Valuation

Total Debt (Millions $)	8,240
Dividend TTM ($)	2.15 $
Dividend Yield TTM (%)	0.65 %
Revenue/Employee (TTM) $	395,817,964
Net Income/Employee (TTM) $	2,385,439
Receivable Turnover (TTM)	13.1
Tangible Book Value (Per Share $)	-82.19

COR's Valuation comparisons

Cencora Inc
current PE on trailing twelve month basis is below Pharmacy Services & Retail Drugstore industry average.

Cencora Inc realized cash outflow of $ -6.15per share in trailing twelve-month period.

Company

35.09

PE TTM

Industry

61.53

PE TTM

Company's Price to Sales ratio is at 0.21.
Pharmacy Services & Retail Drugstore industry's Price to Sales ratio is at 0.24.

Cencora Inc Price to Book Ratio is at 30.12 lower than Industry Avg. of 3149.95. and higher than S&P 500 Avg. of 0.02

• More on COR's Valuation

• Market Capitalization (Millions $)	66,560
• Shares Outstanding (Millions)	195
• Employees	800
• Revenues (TTM) (Millions $)	316,654
• Net Income (TTM) (Millions $)	1,908
• Cash Flow (TTM) (Millions $)	-1,201
• Capital Exp. (TTM) (Millions $)	-600
• Total Debt (Millions $)	8,240
• Dividend TTM ($)	2.15 $
• Dividend Yield TTM (%)	0.65 %
• Revenue/Employee (TTM) $	395,817,964
• Net Income/Employee(TTM) $	2,385,439
• Receivable Turnover Ratio (TTM)	13.1
• Tangible Book Value (Per Share $)	-82.19

• Market Capitalization (Millions $)	66,560
• Shares Outstanding (Millions)	195
• Employees	800
• Revenues (TTM) (Millions $)	316,654
• Net Income (TTM) (Millions $)	1,908
• Cash Flow (TTM) (Millions $)	-1,201
• Capital Exp. (TTM) (Millions $)	-600

COR's Profitability Comparisons

Cencora Inc faced margin deterioration, primarily through cost pressure. Operating Margin fell in third quarter of 2025 to 1.08 % from 1.37 % in II. Quarter.

Cencora Inc net profit margin of 0.86 % is currently ranking no. 6 in Pharmacy Services & Retail Drugstore industry, ranking no. 109 in Retail sector and number 2204 in S&P 500.

Profitability by Segment
Total	0.86 %

	*Ratio*
• Capital Ratio (MRQ)	0.9
• Total Debt to Equity (MRQ)	3.73
• Tangible Leverage Ratio (MRQ)	-
• Asset Turnover Ratio (TTM)	4.52
• Inventory Turnover Ratio (TTM)	15.55

COR's Profitability Comparisons

Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.